CooperSurgical, a global leader in women’s healthcare, today announced the launch of a new inserter designed for single-hand placement of Paragard, which was recently approved by the U.S. Food and Drug Administration (FDA). The new single-hand inserter simplifies the placement process for healthcare providers, making Paragard an even more accessible contraceptive choice for both providers and patients. Paragard, the #1 prescribed copper intrauterine device (IUD), is a tried and true, non-hormonal contraceptive option with more than 30 years of clinical use.
“Paragard has been a reliable contraceptive choice for patients for over three decades due to its continuous 10-year efficacy, immediate reversibility, and hormone-free composition,” said Dr. Lee P. Shulman, board-certified obstetrician-gynecologist and professor at Northwestern University’s Feinberg School of Medicine. “The new single-hand inserter is intuitive for providers. It simplifies the insertion process, making it convenient for healthcare providers and their patients.”
Paragard is immediately reversible and offers over 99% efficacy for up to 10 years providing women with reliable, long-term contraception. A Paragard market survey found that 91% of users ages 25-50 were satisfied with Paragard overall after at least one year. The newly approved inserter, with its built-in loading tip and single-hand functionality, simplifies the placement procedure without compromising the reliability of Paragard itself.
“We are constantly striving to meet the evolving needs of healthcare providers, and the patients they serve,” said Holly Sheffield, President of CooperSurgical. “With nearly 8 million women choosing Paragard, the new inserter simplifies the placement process and marks a significant milestone for the product. It reaffirms our mission to deliver innovative and safe solutions that positively impact the lives of patients and providers everywhere.”
